Nov 04 (Reuters) - Procept Biorobotics Q3 net income USD -21.411 million.
- Q3 revenue USD 83.327 million vs. IBES estimate USD 80.9 million
- outlook FY gross margin 64-64.5%
- outlook FY revenue growth 26-32%
Nov 04 (Reuters) - Procept Biorobotics Q3 net income USD -21.411 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.